Jul 21, 2026 07:02AM
Jul 15, 2026 07:01AM
Jun 26, 2026 04:05PM
May 29, 2026 08:02AM
Apr 22, 2026 08:04AM
Apr 14, 2026 08:04AM
Apr 2, 2026 06:09AM Tempest Therapeutics (TPST) files for 2.78M share offering by selling stockholders
Feb 25, 2026 07:59AM
Feb 11, 2026 06:59AM
Feb 4, 2026 04:48PM
Jan 22, 2026 06:04AM
Dec 9, 2025 04:54PM
Nov 19, 2025 09:02AM
Nov 5, 2025 04:17PM Tempest Therapeutics (TPST) Misses Q3 EPS by 79c
Sep 8, 2025 07:01AM
Aug 11, 2025 04:57PM
Jul 28, 2025 07:00AM
Jun 30, 2025 08:10AM
Jun 11, 2025 08:01AM
Jun 5, 2025 10:28AM
May 13, 2025 06:22PM Tempest Therapeutics, Inc. (TPST) Misses Q1 EPS by 290c
Apr 21, 2025 08:01AM
Apr 10, 2025 06:02AM
Apr 9, 2025 04:30PM
Mar 28, 2025 06:47AM
Mar 13, 2025 08:00AM
Feb 10, 2025 08:00AM
Jan 6, 2025 08:03AM Tempest Therapeutics (TPST) Receives FDA Orphan Drug Designation for Amezalpat
Nov 13, 2024 09:30AM
Nov 12, 2024 04:22PM
Nov 12, 2024 08:01AM
Oct 14, 2024 10:41AM
Oct 11, 2024 06:39AM
Oct 10, 2024 07:01AM
Aug 21, 2024 08:02AM Tempest Therapeutics (TPST) Appoints Troy M. Wagner as VP of Quality Assurance
Aug 16, 2024 10:53AM
Aug 15, 2024 08:00AM
Jul 19, 2024 04:33PM

423,040 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All